AMITYVILLE, N.Y.--(BUSINESS WIRE)--Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK) announced today that the US Food and Drug Administration (FDA) has granted an approval to the Company’s Abbreviated New Drug Application (ANDA) for Hydrocodone Bitartrate and Homatropine Methylbromide Syrup, the generic equivalent of Endo Pharmaceuticals’ Hycodan®. Hydrocodone Bitartrate and Homatropine Methylbromide Syrup is indicated for the symptomatic relief of cough and had sales of approximately $5 million for 2006 according to IMS. The Company expects to start marketing the product immediately.
